Artwork

Contenuto fornito da Sal Daher. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Sal Daher o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Player FM - App Podcast
Vai offline con l'app Player FM !

Eddie Martucci, PhD - Digital Therapy for ADHD

38:01
 
Condividi
 

Manage episode 378032526 series 1318661
Contenuto fornito da Sal Daher. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Sal Daher o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.

Angel Scale Biotech: Learn More

Rather than purloin my kids' Ritalin, I play EndeavorOTC daily to improve my attention and be sharper. Eddie Martucci, PhD is the founder of Akili that developed the app which is backed by real science. In fact, the kid's version is FDA-cleared to treat ADHD in 8-12 year olds. Don't miss this great chat.

Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish and Richardson.

Highlights:

  • Sal Daher Introduces Eddie Martucci

  • The Science Behind EndeavorOTC

  • "... This is not IQ. This is attention. You can have extremely high IQ or low IQ and have a high attention score and low IQ or vice versa..."

  • "... people with ADHD, it is not that they don't want to pay attention ... It's that that system of the brain that allows you to filter out what's irrelevant to your goal and focus in on what's relevant, that part of the brain, that interference filter is weakened..."

  • "... You cannot become addicted to it because can't do it for more than 25 minutes period..."

  • Eddie's Entrepreneurial Journey

  • Advice to the Audience

Topics: discovering entrepreneurship, founding story, product

  continue reading

311 episodi

Artwork
iconCondividi
 
Manage episode 378032526 series 1318661
Contenuto fornito da Sal Daher. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Sal Daher o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.

Angel Scale Biotech: Learn More

Rather than purloin my kids' Ritalin, I play EndeavorOTC daily to improve my attention and be sharper. Eddie Martucci, PhD is the founder of Akili that developed the app which is backed by real science. In fact, the kid's version is FDA-cleared to treat ADHD in 8-12 year olds. Don't miss this great chat.

Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish and Richardson.

Highlights:

  • Sal Daher Introduces Eddie Martucci

  • The Science Behind EndeavorOTC

  • "... This is not IQ. This is attention. You can have extremely high IQ or low IQ and have a high attention score and low IQ or vice versa..."

  • "... people with ADHD, it is not that they don't want to pay attention ... It's that that system of the brain that allows you to filter out what's irrelevant to your goal and focus in on what's relevant, that part of the brain, that interference filter is weakened..."

  • "... You cannot become addicted to it because can't do it for more than 25 minutes period..."

  • Eddie's Entrepreneurial Journey

  • Advice to the Audience

Topics: discovering entrepreneurship, founding story, product

  continue reading

311 episodi

Wszystkie odcinki

×
 
Loading …

Benvenuto su Player FM!

Player FM ricerca sul web podcast di alta qualità che tu possa goderti adesso. È la migliore app di podcast e funziona su Android, iPhone e web. Registrati per sincronizzare le iscrizioni su tutti i tuoi dispositivi.

 

Guida rapida